MICHAEL JOHN TOMSICEK
CIK 1570392 · Chief Financial Officer · last filed 2026-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$127.1K
Companies
8
Total Filings
40
Lifetime Open-Market Net
-$5.65M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRV | Director | 9,366 | $1.48 | $13.9K | $0 | 4 | 2026-05-20 |
| MIST | Director | 15,000 | $1.27 | $19.1K | $79.8K | 7 | 2025-06-12 |
| CRSP | Chief Financial Officer | 1,891 | $49.80 | $94.2K | -$5.61M | 10 | 2021-08-10 |
| CRISPR Therapeutics AG (PZRX) Delisted | Chief Financial Officer | — | — | — | $0 | 1 | 2017-11-14 |
| ABIOMED INC (ABMD) Delisted | Vice President, CFO | 27,081 | $381.02 | $10.32M | $0 | 3 | 2017-07-18 |
| ABIOMED INC (APOL) Delisted | Vice President, CFO | 26,800 | — | — | $0 | 2 | 2016-05-26 |
| CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | SVP & Chief Financial Officer | 0 | — | — | -$67.7K | 6 | 2015-01-21 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | SVP & Chief Financial Officer | 3,318 | — | — | -$49.6K | 7 | 2013-10-02 |
Recent Filings · Page 3 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-09 | CRSP | Grant (A) | — | $0 | EDGAR |
| 2017-11-14 | CRISPR Therapeutics AG (PZRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-18 | ABIOMED INC (ABMD) Delisted | Tax (F) | −3,925 | -$569.4K | EDGAR |
| 2017-05-26 | ABIOMED INC (ABMD) Delisted | Tax (F) | −1,567 | -$211.1K | EDGAR |
| 2017-05-17 | ABIOMED INC (ABMD) Delisted | Grant (A) | +9,698 | $0 | EDGAR |
| 2016-05-26 | ABIOMED INC (APOL) Delisted | Grant (A) | +1,800 | $0 | EDGAR |
| 2015-07-20 | ABIOMED INC (APOL) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2015-01-21 | CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Mixed | −15,964 | -$1.63M | EDGAR |
| 2014-12-31 | CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Mixed | +8,633 | -$674.8K | EDGAR |
| 2014-10-02 | CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Other (J) | +63 | $4.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.